Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FUTURE-T: Transferon for Acute Respiratory Infection (COVID-19)
NCT04379479Phase 2Unknown
- Sponsor
- Instituto Politécnico Nacional
- Start
- May 2020
- Primary completion
- Aug 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) and Acute Respiratory Infection (ARI) comparing Transferon + Paracetamol with Placebo + Paracetamol (2 arms). Primary endpoint: Contingency scale to assess the severity of acute respiratory disease at 35 days. Status: unknown.
02
Drugs
Transferon
03
Conditions
coronavirus disease 2019 (COVID-19)Acute Respiratory Infection (ARI)
Beyond the preview
Go deeper on NCT04379479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04379479.